Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Vor Biopharma Inc’s stock clocked out at $2.4, down -10.11% from its previous closing price of $2.67. In other words, the price has decreased by -$10.11 from its previous closing price. On the day, 30.72 million shares were traded. VOR stock price reached its highest trading level at $3.29 during the session, while it also had its lowest trading level at $2.36.
Ratios:
To gain a deeper understanding of VOR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.88 and its Current Ratio is at 3.88. In the meantime, Its Debt-to-Equity ratio is 0.47 whereas as Long-Term Debt/Eq ratio is at 0.40.
On July 26, 2022, Wedbush started tracking the stock assigning a Outperform rating and target price of $18.
On April 27, 2022, Goldman started tracking the stock assigning a Neutral rating and target price of $6.Goldman initiated its Neutral rating on April 27, 2022, with a $6 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 02 ’25 when ROBERT ANG bought 44,936 shares for $1.79 per share.
ROBERT ANG bought 40,468 shares of VOR for $69,613 on Jul 01 ’25. On Jun 30 ’25, another insider, ROBERT ANG, who serves as the Officer of the company, bought 40,627 shares for $1.73 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VOR now has a Market Capitalization of 299904000 and an Enterprise Value of 173181424.
Stock Price History:
The Beta on a monthly basis for VOR is 2.01, which has changed by 1.542373 over the last 52 weeks, in comparison to a change of 0.10500872 over the same period for the S&P500. Over the past 52 weeks, VOR has reached a high of $3.20, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 356.61%, while the 200-Day Moving Average is calculated to be 183.04%.
Shares Statistics:
It appears that VOR traded 16.10M shares on average per day over the past three months and 83802550 shares per day over the past ten days. A total of 124.85M shares are outstanding, with a floating share count of 76.86M. Insiders hold about 38.49% of the company’s shares, while institutions hold 42.26% stake in the company. Shares short for VOR as of 1749772800 were 3217909 with a Short Ratio of 0.20, compared to 1747267200 on 2758424. Therefore, it implies a Short% of Shares Outstanding of 3217909 and a Short% of Float of 7.0700005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of Vor Biopharma Inc (VOR) is currently attracting attention from 3.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.02 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.58 and -$0.88 for the fiscal current year, implying an average EPS of -$0.69. EPS for the following year is -$0.38, with 4.0 analysts recommending between -$0.07 and -$0.69.
